Neurologic Imaging

How Should You Monitor an Untreated Cerebral Aneurysm? An ACR-Guided Workflow

·
How Should You Monitor an Untreated Cerebral Aneurysm? An ACR-Guided Workflow

A 62-year-old patient with a history of a 4 mm anterior communicating artery aneurysm, found incidentally five years ago, is in your clinic for their annual follow-up. They remain asymptomatic, and the decision at the time of discovery was conservative management with imaging surveillance. Now, it’s time to order this year’s study to assess for stability, and you need to choose the most appropriate, safest, and effective imaging modality for this long-term monitoring. This clinical workflow article details the American College of Radiology (ACR) guidelines for this exact scenario: surveillance of a known, untreated cerebral aneurysm. For this presentation, MRA head without IV contrast is rated ‘Usually Appropriate’ as the primary recommended study.

Who Fits the Scenario of Untreated Aneurysm Surveillance?

This guidance applies specifically to the longitudinal monitoring of an asymptomatic patient with a known, unruptured intracranial aneurysm (UIA) who is being managed conservatively. The primary goal of imaging is to detect growth or morphological changes that might increase the risk of rupture and warrant a re-evaluation of treatment options. It is crucial to distinguish this elective surveillance scenario from other, more urgent clinical presentations.

This workflow does not apply if your patient presents with:

  • New, acute symptoms: A patient describing a “thunderclap” headache or exhibiting new focal neurologic deficits requires an emergent workup for a potential subarachnoid hemorrhage (SAH). That pathway begins with a non-contrast head CT, a different clinical scenario with its own distinct imaging algorithm.
  • A previously treated aneurysm: Patients who have undergone endovascular coiling or surgical clipping of an aneurysm follow a separate post-treatment surveillance protocol. The imaging goals in that context are to assess for aneurysm recanalization, parent vessel patency, or the stability of the clip/coil mass, which may require different imaging techniques.
  • A need for initial screening: An individual with risk factors for aneurysm formation (e.g., two or more first-degree relatives with aneurysms, certain connective tissue diseases) but no known aneurysm would undergo high-risk screening, not surveillance.

This article is exclusively for the planned, periodic imaging of a diagnosed and untreated aneurysm in a patient who remains at their clinical baseline.

What Are You Assessing During Aneurysm Surveillance?

In the surveillance of an untreated cerebral aneurysm, the imaging study is not meant to discover a new diagnosis but to risk-stratify a known condition. The key questions you are trying to answer with each successive scan revolve around the aneurysm’s stability and the emergence of high-risk features. The “differential” in this context is a set of potential findings that guide management.

Aneurysm Stability
This is the most common and desired outcome of a surveillance scan. A stable aneurysm shows no significant change in its maximum diameter, shape, or overall morphology when compared to a series of prior studies. This finding provides reassurance and supports the continuation of conservative management with ongoing, scheduled imaging.

Aneurysm Growth
An increase in the size of the aneurysm is one of the most robust predictors of future rupture. While there is no single universally agreed-upon threshold, growth of 1-2 mm or more is typically considered significant and serves as a major trigger for re-consultation with a neurovascular specialist to discuss potential intervention.

Adverse Morphological Change
Sometimes, an aneurysm’s risk profile can increase even without a notable change in its largest dimension. The development of new, irregular features suggests underlying wall instability. Key changes to look for include the formation of a daughter sac (a small outpouching or bleb from the aneurysm dome), an increase in lobulation, or a transition from a smooth, saccular shape to a more complex, irregular one.

De Novo Aneurysm Formation
While the primary focus is the known aneurysm, the surveillance study also assesses the entire intracranial vasculature. Patients with one aneurysm have a higher propensity to form others. A less common but important finding is the identification of a new, de novo aneurysm elsewhere in the cerebral circulation that will require its own characterization and management plan.

Why Is MRA Head Without IV Contrast the Recommended Study for Aneurysm Surveillance?

The American College of Radiology (ACR) designates MRA head without IV contrast as ‘Usually Appropriate’ for the surveillance of a known, untreated cerebral aneurysm. This recommendation is based on its excellent diagnostic capability combined with a superior safety profile for longitudinal monitoring.

The standard technique for this indication is 3D Time-of-Flight (TOF) MRA. This sequence is highly sensitive to flowing blood, allowing it to generate detailed, high-resolution angiographic images of the cerebral arteries without requiring an injection of gadolinium-based contrast. Most importantly, it involves no ionizing radiation (0 mSv), which is a paramount consideration for any condition that requires repeated imaging studies over a patient’s lifetime. Minimizing cumulative radiation exposure is a core principle of safe and appropriate imaging.

How Do Alternatives Compare?

  • CTA head with IV contrast: This study is also rated ‘Usually Appropriate’ and is an excellent alternative. It can provide superb anatomical detail, is less susceptible to motion artifact, and is significantly faster to acquire than MRA. However, it necessitates both an injection of iodinated contrast material and exposure to ionizing radiation (adult relative radiation level: ☢☢☢ 1-10 mSv). For this reason, while it is a first-rate diagnostic tool, MRA is often preferred for routine, repetitive surveillance to avoid the cumulative effects of radiation and contrast exposure. CTA becomes the primary choice if a patient has a contraindication to MRI, such as an incompatible implanted medical device.
  • Arteriography (Digital Subtraction Angiography): Rated as ‘May be appropriate’, conventional catheter arteriography is the invasive gold standard for vascular imaging. It provides the highest spatial and temporal resolution. However, it involves arterial catheterization, which carries a small but significant risk of neurologic complications (including stroke), access site injury, and higher radiation dose. Its use in surveillance is therefore reserved for specific situations, such as clarifying an equivocal finding on a non-invasive study or for definitive pre-procedural planning if an aneurysm shows growth and intervention is being considered.

For most patients in this scenario, the combination of high diagnostic accuracy and a complete absence of radiation makes MRA head without IV contrast the optimal choice for long-term follow-up. Once you’ve decided on MRA head without IV contrast, our protocol guide covers the technique, contrast, and reading principles: MRA Brain Without Contrast (3D TOF).

What Is the Downstream Workflow After a Surveillance MRA?

The results of the surveillance MRA directly inform the next steps in the patient’s management plan. The workflow branches based on whether the aneurysm is stable, has grown, or if the findings are unclear.

If the Aneurysm Is Stable
When the MRA report confirms no significant interval change in the aneurysm’s size or morphology, the patient can be reassured. The current conservative management plan is reaffirmed, and they should continue with their established surveillance schedule. For very small aneurysms that have been stable for many years, the imaging interval may be cautiously lengthened in consultation with a neurovascular specialist.

If the Aneurysm Shows Growth or High-Risk Change
This is a critical finding that alters the management course. If the MRA demonstrates definitive growth or the development of a new high-risk feature like a daughter sac, the patient’s risk of rupture has likely increased. The immediate next step is a referral (or re-referral) to a neurosurgeon or neuro-interventional radiologist. This specialist will review the imaging, discuss the updated risk-benefit ratio of intervention versus continued observation with the patient, and may order a catheter-based arteriogram for more detailed analysis and treatment planning.

If the Findings Are Indeterminate
Occasionally, an MRA may be limited by technical factors like patient motion artifact, or it may show a subtle change that is equivocal. In these cases, the next step is often to obtain a complementary imaging study. A CTA head with IV contrast is frequently used to clarify ambiguous MRA findings, as it provides a different type of image contrast and is less prone to certain artifacts. If the anatomy remains uncertain after both MRA and CTA, an arteriogram may be necessary for a definitive assessment.

Common Pitfalls in Aneurysm Surveillance and When to Escalate

Effective long-term surveillance requires consistency and careful comparison. Avoiding common pitfalls can ensure that subtle but important changes are not missed.

  • Inconsistent Technique: Comparing images from different scanners with different MRA sequence parameters can make it difficult to determine true aneurysm growth. Whenever possible, patients should have their follow-up imaging performed at the same institution to ensure consistency.
  • Fixating on a Single Measurement: Relying solely on a single diameter measurement can be misleading. A comprehensive assessment must include aneurysm morphology, as the development of a daughter sac can significantly increase risk even with minimal size change.
  • Unavailable Prior Studies: The single most critical element for surveillance is the availability of prior imaging for direct comparison. Always ensure the interpreting radiologist has access to the full history of previous scans.
  • Ignoring Patient Symptoms: Surveillance imaging is for asymptomatic patients. Do not use this elective workflow for a patient with a new, severe headache or neurologic deficit. Such a presentation is a medical emergency requiring an immediate and different diagnostic pathway to rule out rupture.

If a patient on a surveillance plan develops any new, concerning neurologic symptoms, escalate immediately to an emergent evaluation.

Related ACR Topics and Tools

Navigating imaging decisions requires access to the latest guidelines and technical information. The following resources can help you apply appropriateness criteria to other clinical scenarios and understand the technical details of the recommended studies.

Frequently Asked Questions

How often should an untreated cerebral aneurysm be monitored with imaging?

The optimal surveillance interval is not standardized and depends on the aneurysm’s size, location, and morphology, as well as patient-specific factors. A common approach is a baseline scan at 6-12 months after initial diagnosis, followed by annual scans for several years. If the aneurysm remains stable, the interval may be extended to every 2-5 years, based on guidance from neurovascular specialists.

What should I order for aneurysm surveillance if my patient cannot get an MRI?

If a patient has a contraindication to MRI (e.g., a non-compatible pacemaker, cochlear implant, or severe claustrophobia), CTA head with IV contrast is the recommended alternative. It is also rated ‘Usually Appropriate’ by the ACR and provides excellent diagnostic information, though it involves radiation and iodinated contrast.

Is CTA with contrast a better test than MRA without contrast for this purpose?

Neither is definitively ‘better’ in all cases; they are complementary. Both are rated ‘Usually Appropriate’ by the ACR for this scenario. MRA without contrast is often preferred for routine, long-term surveillance because it avoids ionizing radiation and contrast agents. CTA is faster and can be better for visualizing the aneurysm’s relationship to adjacent bony structures. The choice depends on balancing diagnostic needs with the long-term safety profile.

What amount of aneurysm growth on imaging is considered significant?

There is no universal consensus, but many experts consider an increase in maximum diameter of 1 to 2 millimeters to be significant growth that warrants a discussion about potential intervention. Any measurable growth, especially if it occurs over a short interval, should prompt a consultation with a neurosurgeon or neuro-interventional radiologist.

Does the aneurysm’s location affect the surveillance strategy?

Yes, location is a key factor in risk assessment. For example, aneurysms in the posterior circulation (e.g., basilar artery) are generally considered to have a higher rupture risk per size than those in the anterior circulation. As a result, a posterior circulation aneurysm might be monitored more frequently or considered for treatment at a smaller size.

Reviewed by Pouyan Golshani, MD, Interventional Radiologist — May 29, 2026